re: Ann: CGP selects ChinaMed as manufacturin... Well at the moment the market values ISN a lot more than our CGP.That is the reality,and you can say what ever you like about it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025